A study by scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) introduces a more cost-effective, scalable ...

BofA analyst Michael Ryskin lowered the firm’s price target on 10x Genomics (TXG) to $12 from $16 and keeps a Neutral rating on the shares.

EDT Cathie Wood’s ARK Investment buys 191.5K shares of 10x Genomics (TXG) todayStay Ahead of the Market: Discover outperforming stocks ...

What Happened? A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & ...

Cactus 2.9.7 is available in the following forms: Docker Image: quay.io/comparative-genomics-toolkit/cactus:v2.9.7 GPU-accelerated Docker Image: quay.io/comparative ...

Illumina ranks as the largest player in genetic sequencing. Other top genetic sequencing companies include PacBio, 10X Genomics, and Oxford Nanopore Technologies. Key findings are powered by ...

Founded in 2012, 10x Genomics (NASDAQ:TXG) is a biotech company developing gene-sequencing solutions based in the US. In a rather competitive market, TXG’s focus has been on single-cell and ...

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States Department of Pharmacology, University of ...

10x Genomics and Syncell streamline cutting-edge analytics for life science research, while Nabla Bio is using generative AI to design completely new antibodies. Protagonist Therapeutics is ...

Nvidia’s RTX 50-series GPUs are making quite a splash regarding the incredible capabilities of DLSS 4, all of the neural rendering techniques, and AI, which is now used to achieve some bonkers ...